ketotifen has been researched along with Cerebral Hemorrhage in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Cerebral Hemorrhage: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de las Nieves, M | 1 |
| Poveda, F | 1 |
| Queipo de Llano, MP | 1 |
| González-Hermoso, C | 1 |
1 other study available for ketotifen and Cerebral Hemorrhage
| Article | Year |
|---|---|
[System mastocytosis: presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b].
Topics: Bone Marrow; Cerebral Hemorrhage; Combined Modality Therapy; Fatal Outcome; Female; Histamine Antago | 1997 |